ReviewHematology. American Society of Hematology. Education Program2022
Antibodies and bispecifics for multiple myeloma: effective effector therapy.
Christopher Cipkar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this papercites it